相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
Matthew James Armstrong et al.
LANCET (2016)
Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
Eduardo Vilar-Gomez et al.
GASTROENTEROLOGY (2015)
Double-blind Randomized Placebo-controlled Clinical Trial of Omega 3 Fatty Acids for the Treatment of Diabetic Patients With Nonalcoholic Steatohepatitis
Srinivasan Dasarathy et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2015)
Effects of n-3 fish oil on metabolic and histological parameters in NASH: A double-blind, randomized, placebo-controlled trial
Curtis K. Argo et al.
JOURNAL OF HEPATOLOGY (2015)
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
Brent A. Neuschwander-Tetri et al.
LANCET (2015)
Vitamin D: a new player in non-alcoholic fatty liver disease?
Myrto Eliades et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Readiness for behaviour change in non-alcoholic fatty liver disease: implications for multidisciplinary care models
Karen E. Stewart et al.
LIVER INTERNATIONAL (2015)
Renin-angiotensin system and fibrosis in non-alcoholic fatty liver disease
George B. Goh et al.
LIVER INTERNATIONAL (2015)
Therapeutic role of niacin in the prevention and regression of hepatic steatosis in rat model of nonalcoholic fatty liver disease
Shobha H. Ganji et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2014)
Relationship between Hemoglobin Levels and Risk for Suspected Non-Alcoholic Fatty Liver in Taiwanese Adults
Chyi-Huey Bai et al.
CHINESE JOURNAL OF PHYSIOLOGY (2014)
Serum Ferritin Levels Lack Diagnostic Accuracy for Liver Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
Paul Angulo et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)
Adherence to the Mediterranean diet is associated with the severity of non-alcoholic fatty liver disease
Meropi D. Kontogianni et al.
CLINICAL NUTRITION (2014)
The effects of ezetimibe on non-alcoholic fatty liver disease and glucose metabolism: a randomised controlled trial
Yumie Takeshita et al.
DIABETOLOGIA (2014)
Statin therapy is associated with a reduced risk of non-alcoholic fatty liver in overweight individuals
Catherine E. de Keyser et al.
DIGESTIVE AND LIVER DISEASE (2014)
Pentoxifylline for the treatment of nonalcoholic fatty liver disease: a meta-analysis of randomized double-blind, placebo-controlled studies
Tao Zeng et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2014)
Clinical usage of serum ferritin to assess liver fibrosis in patients with non-alcoholic fatty liver disease: Proceed with caution
Masato Yoneda et al.
HEPATOLOGY RESEARCH (2014)
Hepatic steatosis exacerbated by endoplasmic reticulum stress-mediated downregulation of FXR in aging mice
Xuelian Xiong et al.
JOURNAL OF HEPATOLOGY (2014)
Dietary recommendations for patients with nonalcoholic fatty liver disease
Angelika Kargulewicz et al.
PRZEGLAD GASTROENTEROLOGICZNY (2014)
Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
Yoshio Sumida et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Does vitamin D improve liver enzymes, oxidative stress, and inflammatory biomarkers in adults with non-alcoholic fatty liver disease? A randomized clinical trial
Nasrin Sharifi et al.
ENDOCRINE (2014)
Hypocaloric high-protein diet improves clinical and biochemical markers in patients with nonalcoholic fatty liver disease (NAFLD)
Sebastiao Mauro Bezerra Duarte et al.
NUTRICION HOSPITALARIA (2014)
Phase II clinical trial of phlebotomy for non-alcoholic fatty liver disease
M. D. Beaton et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Meta-analysis: vitamin D and non-alcoholic fatty liver disease
M. Eliades et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
The role of Ursodeoxycholic acid in non-alcoholic steatohepatitis: a systematic review
Zun Xiang et al.
BMC GASTROENTEROLOGY (2013)
Prognostic Significance of AMPK Activation and Therapeutic Effects of Metformin in Hepatocellular Carcinoma
Longyi Zheng et al.
CLINICAL CANCER RESEARCH (2013)
Coffee Reduces Risk for Hepatocellular Carcinoma: An Updated Meta-analysis
Francesca Bravi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
The Mediterranean diet improves the systemic lipid and DNA oxidative damage in metabolic syndrome individuals. A randomized, controlled, trial
Maria Teresa Mitjavila et al.
CLINICAL NUTRITION (2013)
Dual Peroxisome Proliferator-Activated Receptor α/δ Agonist GFT505 Improves Hepatic and Peripheral Insulin Sensitivity in Abdominally Obese Subjects
Bertrand Cariou et al.
DIABETES CARE (2013)
Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
Sunder Mudaliar et al.
GASTROENTEROLOGY (2013)
Hepatoprotective Effects of the Dual Peroxisome Proliferator-Activated Receptor Alpha/Delta Agonist, GFT505, in Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
Bart Staels et al.
HEPATOLOGY (2013)
Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD)
Siddharth Verma et al.
LIVER INTERNATIONAL (2013)
被撤回的出版物: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet (Retracted article. See vol. 378, pg. 2441, 2018)
Ramon Estruch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Effects of probiotics on nonalcoholic fatty liver disease: A meta-analysis
Yan-Yan Ma et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Prospective histopathologic evaluation of lifestyle modification in nonalcoholic fatty liver disease: a randomized trial
Carly Eckard et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2013)
Meta-analysis: pioglitazone improves liver histology and fibrosis in patients with non-alcoholic steatohepatitis
E. Boettcher et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Effect of short-term carbohydrate overfeeding and long-term weight loss on liver fat in overweight humans
Ksenia Sevastianova et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2012)
The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
Naga Chalasani et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Metformin Prevents Liver Tumorigenesis by Inhibiting Pathways Driving Hepatic Lipogenesis
Kavita Bhalla et al.
CANCER PREVENTION RESEARCH (2012)
Cellular and molecular mechanisms of metformin: an overview
Benoit Viollet et al.
CLINICAL SCIENCE (2012)
Sibutramine Effects on Central Mechanisms Regulating Energy Homeostasis
Joao R. Araujo et al.
Current Neuropharmacology (2012)
Bile Acids Acutely Stimulate Insulin Secretion of Mouse β-Cells via Farnesoid X Receptor Activation and KATP Channel Inhibition
Martina Duefer et al.
DIABETES (2012)
Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials
G. Musso et al.
DIABETOLOGIA (2012)
Bifidobacterium longum with Fructo-Oligosaccharides in Patients with Non Alcoholic Steatohepatitis
Michele Malaguarnera et al.
DIGESTIVE DISEASES AND SCIENCES (2012)
Farnesoid X receptor targeting to treat nonalcoholic steatohepatitis
Luciano Adorini et al.
DRUG DISCOVERY TODAY (2012)
The Role of Metformin in the Management of NAFLD
Angela Mazza et al.
EXPERIMENTAL DIABETES RESEARCH (2012)
Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: A randomized controlled trial
Carmela Loguercio et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
A phase 2, randomized, double-blind, placebo-controlled study of GS-9450 in subjects with nonalcoholic steatohepatitis
Vlad Ratziu et al.
HEPATOLOGY (2012)
Regular coffee but not espresso drinking is protective against fibrosis in a cohort mainly composed of morbidly obese European women with NAFLD undergoing bariatric surgery
Rodolphe Anty et al.
JOURNAL OF HEPATOLOGY (2012)
A systematic review and meta-analysis of the effect of aerobic vs. resistance exercise training on visceral fat
I. Ismail et al.
OBESITY REVIEWS (2012)
Effect of Bariatric Surgery on Liver Fibrosis
Myriam Moretto et al.
OBESITY SURGERY (2012)
Improved Glycaemia Correlates with Liver Fat Reduction in Obese, Type 2 Diabetes, Patients Given Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists
Daniel J. Cuthbertson et al.
PLOS ONE (2012)
Dyslipidemia in Patients with Nonalcoholic Fatty Liver Disease
Hemant Chatrath et al.
SEMINARS IN LIVER DISEASE (2012)
Lifestyle intervention in non-alcoholic fatty liver disease in Chengyang District, Qingdao, China
Wei-Hui Sun et al.
WORLD JOURNAL OF HEPATOLOGY (2012)
Enteric-coated cysteamine for the treatment of paediatric non-alcoholic fatty liver disease
R. Dohil et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Physical Activity Recommendations, Exercise Intensity, and Histological Severity of Nonalcoholic Fatty Liver Disease
Kristin D. Kistler et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Effects of the New Dual PPARα/δ Agonist GFT505 on Lipid and Glucose Homeostasis in Abdominally Obese Patients With Combined Dyslipidemia or Impaired Glucose Metabolism
Bertrand Cariou et al.
DIABETES CARE (2011)
Mechanisms Linking Nonalcoholic Fatty Liver Disease with Coronary Artery Disease
W. Nseir et al.
DIGESTIVE DISEASES AND SCIENCES (2011)
The role of the renin-angiotensin system in liver fibrosis
M. Kamruzzman Munshi et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2011)
Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss
Kate Hallsworth et al.
GUT (2011)
Pentoxifylline Improves Nonalcoholic Steatohepatitis: A Randomized Placebo-Controlled Trial
Claudia O. Zein et al.
HEPATOLOGY (2011)
Rosiglitazone Versus Rosiglitazone and Metformin Versus Rosiglitazone and Losartan in the Treatment of Nonalcoholic Steatohepatitis in Humans: A 12-Month Randomized, Prospective, Open-Label Trial
Dawn M. Torres et al.
HEPATOLOGY (2011)
Randomized Comparison of Reduced Fat and Reduced Carbohydrate Hypocaloric Diets on Intrahepatic Fat in Overweight and Obese Human Subjects
Sven Haufe et al.
HEPATOLOGY (2011)
Vitamin E and the Risk of Prostate Cancer The Selenium and Vitamin E Cancer Prevention Trial (SELECT)
Eric A. Klein et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease
Hyohun Park et al.
JOURNAL OF GASTROENTEROLOGY (2011)
A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis
Vlad Ratziu et al.
JOURNAL OF HEPATOLOGY (2011)
Paraoxonase-1 activity, malondialdehyde and glutathione peroxidase in non-alcoholic fatty liver disease and the effect of atorvastatin
Waleed Samy et al.
Arab Journal of Gastroenterology (2011)
Exenatide in the Treatment of Diabetic Patients With Non-Alcoholic Steatohepatitis: A Case Series
Patrick R. Kenny et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Betaine improves nonalcoholic fatty liver and associated hepatic insulin resistance: a potential mechanism for hepatoprotection by betaine
Elango Kathirvel et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2010)
Effect of a 12-Month Intensive Lifestyle Intervention on Hepatic Steatosis in Adults With Type 2 Diabetes
Mariana Lazo et al.
DIABETES CARE (2010)
Gut-Liver Axis and Sensing Microbes
Gyongyi Szabo et al.
DIGESTIVE DISEASES (2010)
Randomized Controlled Trial Testing the Effects of Weight Loss on Nonalcoholic Steatohepatitis
Kittichai Promrat et al.
HEPATOLOGY (2010)
Decreased Survival of Subjects with Elevated Liver Function Tests During a 28-Year Follow-Up
Cecilia Soderberg et al.
HEPATOLOGY (2010)
Increased Fructose Consumption Is Associated with Fibrosis Severity in Patients with Nonalcoholic Fatty Liver Disease
Manal F. Abdelmalek et al.
HEPATOLOGY (2010)
Therapeutic Trials in Nonalcoholic Steatohepatitis: Insulin Sensitizers and Related Methodological Issues
Vlad Ratziu et al.
HEPATOLOGY (2010)
High-Dose Ursodeoxycholic Acid Therapy for Nonalcoholic Steatohepatitis: A Double-Blind, Randomized, Placebo-Controlled Trial
Ulrich F. H. Leuschner et al.
HEPATOLOGY (2010)
A Meta-Analysis of Randomized Trials for the Treatment of Nonalcoholic Fatty Liver Disease
Giovanni Musso et al.
HEPATOLOGY (2010)
Effect of Fenofibrate and Niacin on Intrahepatic Triglyceride Content, Very Low-Density Lipoprotein Kinetics, and Insulin Action in Obese Subjects with Nonalcoholic Fatty Liver Disease
Elisa Fabbrini et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis
Vasilios G. Athyros et al.
LANCET (2010)
NPC1L1 inhibitor ezetimibe is a reliable therapeutic agent for non-obese patients with nonalcoholic fatty liver disease
Munechika Enjoji et al.
LIPIDS IN HEALTH AND DISEASE (2010)
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis.
Arun J. Sanyal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects
W. Philip T. James et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Effect of 6-month nutritional intervention on non-alcoholic fatty liver disease
Maria Cristina Elias et al.
NUTRITION (2010)
A 12-Week Aerobic Exercise Program Reduces Hepatic Fat Accumulation and Insulin Resistance in Obese, Hispanic Adolescents
Gert-Jan van der Heijden et al.
OBESITY (2010)
Non-alcoholic fatty liver disease from pathogenesis to management: an update
G. Musso et al.
OBESITY REVIEWS (2010)
Soft drinks consumption and nonalcoholic fatty liver disease
William Nseir et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults
Jill A. Parnell et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2009)
Metabolic disturbances in non-alcoholic fatty liver disease
Christopher D. Byrne et al.
CLINICAL SCIENCE (2009)
Epidemiology and Natural History of Non-Alcoholic Steatohepatitis
Curtis K. Argo et al.
CLINICS IN LIVER DISEASE (2009)
Prospective Study of the Long-Term Effects of Bariatric Surgery on Liver Injury in Patients Without Advanced Disease
Philippe Mathurin et al.
GASTROENTEROLOGY (2009)
Orlistat for Overweight Subjects with Nonalcoholic Steatohepatitis: A Randomized, Prospective Trial
Stephen A. Harrison et al.
HEPATOLOGY (2009)
Increased Intestinal Permeability and Tight Junction Alterations in Nonalcoholic Fatty Liver Disease
Luca Miele et al.
HEPATOLOGY (2009)
Independent Effects of Physical Activity in Patients with Nonalcoholic Fatty Liver Disease
Alexis St. George et al.
HEPATOLOGY (2009)
Aerobic Exercise Training Reduces Hepatic and Visceral Lipids in Obese Individuals Without Weight Loss
Nathan A. Johnson et al.
HEPATOLOGY (2009)
Thiazolidinediones for the Treatment in NASH Sustained Benefit After Drug Discontinuation?
Curtis K. Argo et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2009)
A Pilot Study Using Simvastatin in the Treatment of Nonalcoholic Steatohepatitis A Randomized Placebo-controlled Trial
Austin Nelson et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2009)
Influence of ethnicity on histological differences in non-alcoholic fatty liver disease
Smruti R. Mohanty et al.
JOURNAL OF HEPATOLOGY (2009)
Silybin, a component of sylimarin, exerts anti-inflammatory and anti-fibrogenic effects on human hepatic stellate cells
Marco Trappoliere et al.
JOURNAL OF HEPATOLOGY (2009)
Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome
Ali Abid et al.
JOURNAL OF HEPATOLOGY (2009)
Effect of dietary monosodium glutamate on trans fat-induced nonalcoholic fatty liver disease
Kate S. Collison et al.
JOURNAL OF LIPID RESEARCH (2009)
Discontinuation due to adverse events in randomized trials of orlistat, sibutramine and rimonabant: a meta-analysis
K. Johansson et al.
OBESITY REVIEWS (2009)
Angiotensin-receptor blockers as therapy for mild-to-moderate hypertension-associated non-alcoholic steatohepatitis
Eugen Florin Georgescu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: population based cohort study
David N. Juurlink et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Effect of Bariatric Surgery on Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis
Rajasekhara R. Mummadi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Nonalcoholic fatty liver disease: the potential role of nutritional management
Isabelle A. Leclercq et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2008)
A pilot trial of fenofibrate for the treatment of non-alcoholic fatty liver disease
C. Fernandez-Miranda et al.
DIGESTIVE AND LIVER DISEASE (2008)
Pharmacokinetics of silymarin is altered in patients with hepatitis C virus and nonalcoholic fatty liver disease and correlates with plasma caspase-3/7 activity
Sarah J. Schrieber et al.
DRUG METABOLISM AND DISPOSITION (2008)
Rosiglitazone for nonalcoholic steatohepatitis: One-year results of the randomized placebo-controlled fatty liver improvement with rosiglitazone therapy (FLIRT) trial
Vlad Ratziu et al.
GASTROENTEROLOGY (2008)
Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis
Guruprasad P. Aithal et al.
GASTROENTEROLOGY (2008)
The Effect of a Probiotic on Hepatic Steatosis
Steven F. Solga et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2008)
Fructose consumption as a risk factor for non-alcoholic fatty liver disease
Xiaosen Ouyang et al.
JOURNAL OF HEPATOLOGY (2008)
Molecular Mechanisms of Lipotoxicity in Nonalcoholic Fatty Liver Disease
Harmeet Malhi et al.
SEMINARS IN LIVER DISEASE (2008)
Effects of n-3 polyunsaturated fatty acids from seal oils on nonalcoholic fatty liver disease associated with hyperlipidemia
Feng-Shang Zhu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Silymarin in the treatment of chronic liver diseases: past and future
János Fehér et al.
ORVOSI HETILAP (2008)
The effect of ras inhibition on the proliferation, apoptosis and matrix metalloproteases activity in rat hepatic stellate cells
Isabel Zvibel et al.
DIGESTIVE DISEASES AND SCIENCES (2008)
Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: Results of a prospective, randomized, double-blind, placebo-controlled, Multicenter trial
James H. Lewis et al.
HEPATOLOGY (2007)
Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease
Giovanni Targher et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2007)
The effects of discontinuing pioglitazone in patients with nonalcoholic steatohepatitis
Glen Lutchman et al.
HEPATOLOGY (2007)
Mortality in randomized trials of antioxidant supplements for primary and secondary prevention - Systematic review and meta-analysis
Goran Bjelakovic et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
The effect of a silybin-vitamin E-phospholipid complex on nonalcoholic fatty liver disease: A pilot study
Carmela Loguercio et al.
DIGESTIVE DISEASES AND SCIENCES (2007)
Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin E in nonalcoholic steatohepatitis
Jean-Francois Dufour et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis
Renata Belfort et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Long-term follow-up of patients with NAFLD and elevated liver enzymes
Mattias Ekstedt et al.
HEPATOLOGY (2006)
Change in liver size and fat content after treatment with Optifast® very low calorie diet
Mark C. Lewis et al.
OBESITY SURGERY (2006)
A pilot study of atorvastatin treatment in dyslipemid, non-alcoholic fatty liver patients
E. Gomez-Dominguez et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease
Shira Zelber-Sagi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study
Vasilios G. Athyros et al.
CURRENT MEDICAL RESEARCH AND OPINION (2006)
Effect of exercise and dietary modification on serum aminotransferase levels in patients with nonalcoholic steatohepatitis
CS Baba et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2006)
Mode of action of fibrates in the regulation of triglyceride and HDL-cholesterol metabolism
JC Fruchart et al.
DRUGS OF TODAY (2006)
Effect of changes on body weight and lifestyle in nonalcoholic fatty liver disease
A Suzuki et al.
JOURNAL OF HEPATOLOGY (2005)
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study):: randomised controlled trial
A Keech et al.
LANCET (2005)
Systematic review of long-term weight loss studies in obese adults: clinical significance and applicability to clinical practice
JD Douketis et al.
INTERNATIONAL JOURNAL OF OBESITY (2005)
Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos Nutrition and Liver Study
G Bedogni et al.
HEPATOLOGY (2005)
Sampling variability of liver biopsy in nonalcoholic fatty liver disease
V Ratziu et al.
GASTROENTEROLOGY (2005)
A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease
E Bugianesi et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: A pilot study
MA Huang et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes
KF Petersen et al.
DIABETES (2005)
Twice-weekly progressive resistance training decreases abdominal fat and improves insulin sensitivity in older men with type 2 diabetes
J Ibañez et al.
DIABETES CARE (2005)
Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population
LS Szczepaniak et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2005)
Meta-analysis: High-dosage vitamin E supplementation may increase all-cause mortality
ER Miller et al.
ANNALS OF INTERNAL MEDICINE (2005)
Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: Results of a randomized trial
KD Lindor et al.
HEPATOLOGY (2004)
Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome - A randomized trial
K Esposito et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity
JD Browning et al.
HEPATOLOGY (2004)
A Pilot Study of Vitamin E Versus Vitamin E and Pioglitazone for the Treatment of Nonalcoholic Steatohepatitis
Arun J. Sanyal et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2004)
Mitochondrial injury in steatohepatitis
D Pessayre et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2004)
Increase in long-chain polyunsaturated fatty acid n-6/n-3 ratio in relation to hepatic steatiosis in patients with non-alcoholic fatty liver disease
J Araya et al.
CLINICAL SCIENCE (2004)
Adherence to a Mediterranean diet and survival in a Greek population
A Trichopoulou et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Non-alcoholic fatty liver disease: lumen-liver interactions and possible role for probiotics
SF Solga et al.
JOURNAL OF HEPATOLOGY (2003)
Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis
G Musso et al.
HEPATOLOGY (2003)
Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome
G Marchesini et al.
HEPATOLOGY (2003)
Ursodeoxycholic acid and atorvastatin in the treatment of nonalcoholic steatohepatitis
M Kiyici et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY (2003)
The utility of radiological imaging in nonalcoholic fatty liver disease
S Saadeh et al.
GASTROENTEROLOGY (2002)
Folate deficiency, methionine metabolism, and alcoholic liver disease
CH Halsted et al.
ALCOHOL (2002)
Non-alcoholic fatty liver disease
P Angulo et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2002)
Nonalcoholic fatty liver disease - A feature of the metabolic syndrome
G Marchesini et al.
DIABETES (2001)
Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders'
KN Lazaridis et al.
JOURNAL OF HEPATOLOGY (2001)
分享论文
